Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuela Hummel

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Frontiers in Oncology|November 11, 2021
Prevalence of the GFI1-36N SNP in Multiple Myeloma Patients and Its Impact on the PrognosisCyrus Khandanpour, Christine Eisfeld, Subbaiah Chary Nimmagadda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2009
ERG expression is an independent prognostic factor and allows refined risk stratification in cytogenetically normal acute myeloid leukemia: a comprehensive analysis of ERG, MN1, and BAALC transcript levels using oligonucleotide microarraysKlaus H Metzeler, Annika Dufour, Tobias Benthaus, et al.
Cell Death & Disease|October 27, 2017
miR-99a reveals two novel oncogenic proteins E2F2 and EMR2 and represses stemness in lung cancerAndrea Feliciano, Yoelsis Garcia-Mayea, Luz Jubierre, et al.
BMC Genomics|June 4, 2013
Microarray and deep sequencing cross-platform analysis of the mirRNome and isomiR variation in response to epidermal growth factorFranc Llorens, Manuela Hummel, Lorena Pantano, et al.
BMC Genomics|June 25, 2011
Multiple platform assessment of the EGF dependent transcriptome by microarray and deep tag sequencing analysisFranc Llorens, Manuela Hummel, Xavier Pastor, et al.
Blood|August 22, 2008
An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemiaKlaus H Metzeler, Manuela Hummel, Clara D Bloomfield, et al.
International Journal of Molecular Sciences|June 27, 2024
Molecular Long-Term Analysis of the GMMG-HD4 Trial in Multiple Myeloma-Patterns of Association of Chromosomal Aberrations with Response and Proliferation Determining Survival in Selecting Treatments in View of Limited Resources in Low- and Middle-Income CountriesAnja Seckinger, Hans Salwender, Hans Martin, et al.
Acta Neuropathologica|December 17, 2015
Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targetsFelix Sahm, Daniel Schrimpf, David T W Jones, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Frontiers in Oncology|November 11, 2021
Prevalence of the GFI1-36N SNP in Multiple Myeloma Patients and Its Impact on the PrognosisCyrus Khandanpour, Christine Eisfeld, Subbaiah Chary Nimmagadda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2009
ERG expression is an independent prognostic factor and allows refined risk stratification in cytogenetically normal acute myeloid leukemia: a comprehensive analysis of ERG, MN1, and BAALC transcript levels using oligonucleotide microarraysKlaus H Metzeler, Annika Dufour, Tobias Benthaus, et al.
Cell Death & Disease|October 27, 2017
miR-99a reveals two novel oncogenic proteins E2F2 and EMR2 and represses stemness in lung cancerAndrea Feliciano, Yoelsis Garcia-Mayea, Luz Jubierre, et al.
BMC Genomics|June 4, 2013
Microarray and deep sequencing cross-platform analysis of the mirRNome and isomiR variation in response to epidermal growth factorFranc Llorens, Manuela Hummel, Lorena Pantano, et al.
BMC Genomics|June 25, 2011
Multiple platform assessment of the EGF dependent transcriptome by microarray and deep tag sequencing analysisFranc Llorens, Manuela Hummel, Xavier Pastor, et al.
Blood|August 22, 2008
An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemiaKlaus H Metzeler, Manuela Hummel, Clara D Bloomfield, et al.
International Journal of Molecular Sciences|June 27, 2024
Molecular Long-Term Analysis of the GMMG-HD4 Trial in Multiple Myeloma-Patterns of Association of Chromosomal Aberrations with Response and Proliferation Determining Survival in Selecting Treatments in View of Limited Resources in Low- and Middle-Income CountriesAnja Seckinger, Hans Salwender, Hans Martin, et al.
Acta Neuropathologica|December 17, 2015
Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targetsFelix Sahm, Daniel Schrimpf, David T W Jones, et al.
Pageof 3